Impact of the COVID-19 pandemic on teaching and research activities in obstetrics and gynecology: a national two-stage, stratified, cluster sampling survey in China.

Impact of the COVID-19 pandemic on teaching and research activities in obstetrics and gynecology: a national two-stage, stratified, cluster sampling survey in China.

Publication date: Oct 11, 2024

Few studies quantified the influence of the coronavirus disease 2019 (COVID-19) pandemic on medical teaching and scientific research activities in China. This is the first national study to investigate such topics from the viewpoint of physicians practicing obstetrics and gynecology in China. This is a national questionnaire survey with online interviews for respondents. This two-stage, stratified, cluster sampling method was applied based on city categories (categories 1 to 3 correspond to  30,000 beds, respectively), hospital levels (primary, secondary, and tertiary), and hospital types (general and specialized) in China among physicians practicing obstetrics and gynecology. Physicians documented notable alterations in both overall and specialized teaching and research engagements. Comparative analyses were conducted across diverse municipal and hospital attributes. Data were collected from a representative sample of 11,806 physicians from 779 hospitals across 157 cities and 31 provinces. Notably, except for online seminars, a minimum reduction of 20% in both overall and specialized teaching and research activities was observed among physicians. Up to 61. 7% (95% confidence interval 59. 3-64. 0) of physicians reported either a complete termination or a > 50% decline in resident training. Compared with category 1 cities and primary hospitals, category 3 cities and tertiary hospitals experienced greater reductions in items of resident or graduate education, visiting scholar, clinical trials, and laboratory studies (adjusted p values 

Open Access PDF

Concepts Keywords
China COVID-19 pandemic
Coronavirus Mainland China
Gynecology Obstetrics and gynecology
Interviews Research
Teaching

Semantics

Type Source Name
disease MESH COVID-19 pandemic
pathway REACTOME Reproduction
disease MESH infection
drug DRUGBANK Ademetionine
drug DRUGBANK Ranitidine
drug DRUGBANK Coenzyme M
disease MESH tics
drug DRUGBANK L-Valine
drug DRUGBANK L-Citrulline
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Etoperidone
drug DRUGBANK Trestolone
pathway REACTOME Translation
disease MESH Rare Diseases
disease IDO process
drug DRUGBANK Calusterone

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *